Sk Biopharmaceutica (Korea) Market Value
| 326030 Stock | 103,800 500.00 0.48% |
| Symbol | 326030 |
Sk Biopharmaceutica 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sk Biopharmaceutica's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sk Biopharmaceutica.
| 01/08/2023 |
| 12/28/2024 |
If you would invest 0.00 in Sk Biopharmaceutica on January 8, 2023 and sell it all today you would earn a total of 0.00 from holding Sk Biopharmaceuticals Co or generate 0.0% return on investment in Sk Biopharmaceutica over 720 days. Sk Biopharmaceutica is related to or competes with ABL Bio, ALTEOGEN, Kmw, and Celltrion Pharm. More
Sk Biopharmaceutica Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sk Biopharmaceutica's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sk Biopharmaceuticals Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 12.81 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 5.77 |
Sk Biopharmaceutica Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sk Biopharmaceutica's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sk Biopharmaceutica's standard deviation. In reality, there are many statistical measures that can use Sk Biopharmaceutica historical prices to predict the future Sk Biopharmaceutica's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.16) | |||
| Treynor Ratio | (0.35) |
Sk Biopharmaceuticals Backtested Returns
At this point, Sk Biopharmaceutica is very steady. Sk Biopharmaceuticals retains Efficiency (Sharpe Ratio) of 0.0128, which indicates the firm had a 0.0128% return per unit of price deviation over the last 3 months. We have found twenty-three technical indicators for Sk Biopharmaceutica, which you can use to evaluate the volatility of the company. Please validate Sk Biopharmaceutica's Standard Deviation of 2.87, mean deviation of 2.15, and Risk Adjusted Performance of (0.01) to confirm if the risk estimate we provide is consistent with the expected return of 0.0366%. Sk Biopharmaceutica has a performance score of 1 on a scale of 0 to 100. The entity owns a Beta (Systematic Risk) of 0.22, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sk Biopharmaceutica's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sk Biopharmaceutica is expected to be smaller as well. Sk Biopharmaceuticals now owns a risk of 2.86%. Please validate Sk Biopharmaceuticals Co coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Sk Biopharmaceuticals Co will be following its current price history.
Auto-correlation | 0.26 |
Poor predictability
Sk Biopharmaceuticals Co has poor predictability. Overlapping area represents the amount of predictability between Sk Biopharmaceutica time series from 8th of January 2023 to 3rd of January 2024 and 3rd of January 2024 to 28th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sk Biopharmaceuticals price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Sk Biopharmaceutica price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | 0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 147.3 M |
Sk Biopharmaceuticals lagged returns against current returns
Autocorrelation, which is Sk Biopharmaceutica stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sk Biopharmaceutica's stock expected returns. We can calculate the autocorrelation of Sk Biopharmaceutica returns to help us make a trade decision. For example, suppose you find that Sk Biopharmaceutica has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sk Biopharmaceutica regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sk Biopharmaceutica stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sk Biopharmaceutica stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sk Biopharmaceutica stock over time.
Current vs Lagged Prices |
| Timeline |
Sk Biopharmaceutica Lagged Returns
When evaluating Sk Biopharmaceutica's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sk Biopharmaceutica stock have on its future price. Sk Biopharmaceutica autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sk Biopharmaceutica autocorrelation shows the relationship between Sk Biopharmaceutica stock current value and its past values and can show if there is a momentum factor associated with investing in Sk Biopharmaceuticals Co.
Regressed Prices |
| Timeline |
Pair Trading with Sk Biopharmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sk Biopharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sk Biopharmaceutica will appreciate offsetting losses from the drop in the long position's value.Moving together with 326030 Stock
Moving against 326030 Stock
| 0.63 | 035420 | Naver | PairCorr |
| 0.63 | 011200 | HMM Co | PairCorr |
| 0.6 | 032640 | LG Uplus | PairCorr |
| 0.41 | 003535 | Hanwha InvestmentSecuri | PairCorr |
| 0.4 | 039240 | Gyeongnam Steel | PairCorr |
The ability to find closely correlated positions to Sk Biopharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sk Biopharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sk Biopharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sk Biopharmaceuticals Co to buy it.
The correlation of Sk Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sk Biopharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sk Biopharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sk Biopharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in 326030 Stock
Sk Biopharmaceutica financial ratios help investors to determine whether 326030 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 326030 with respect to the benefits of owning Sk Biopharmaceutica security.